This finding is relevant for the use of novel immunotherapies, including CAR-T cells, which can induce cytokine signaling after stimulation48, and therapeutic antibodies35 that depend partially on intact tumor IFN and TNF mediated signaling for T-cell-mediated tumor eradication47,49. The gene discussed is TNF; the disease is neoplasm.